News & Blog

Tag Archives: FDA

Survey Results: Clinical Trial Participation

  National Brain Tumor Society, in conjunction with neuro-oncologists, scientific researchers, and the biopharmaceutical industry, is constantly looking for new and better treatments for patients. However, scientific progress in a laboratory does not necessarily always lead to new treatments for patients. First, those laboratory results need to be evaluated and confirmed in high quality clinical trials to ensure […]

GBM AGILE: A Community Galvanized

“GBM is just unacceptable…we no longer accept the status quo.” – Dr. Anna Barker Last week, you likely took notice of the press release, guest blog from Dr. Anna Barker, and a flurry of social media activity related to the announcement of the GBM AGILE coalition and clinical trial. As NBTS is co-chairing the GBM […]

Cancer Research Takes the National Spotlight This Week

Two announcements this week thrust the importance of funding biomedical research into the national spotlight, yet again. This Wednesday, Vice President Joe Biden stepped in front of a podium in the White House Rose Garden and made a long anticipated announcement: his decision regarding a presidential bid. However, after the Vice President revealed his plan […]

Share